162 related articles for article (PubMed ID: 35764659)
1. Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2.
Park HS; Matsuoka Y; Luongo C; Yang L; Santos C; Liu X; Ahlers LRH; Moore IN; Afroz S; Johnson RF; Lafont BAP; Dorward DW; Fischer ER; Martens C; Samal SK; Munir S; Buchholz UJ; Le Nouën C
NPJ Vaccines; 2022 Jun; 7(1):72. PubMed ID: 35764659
[TBL] [Abstract][Full Text] [Related]
2. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters.
Liu X; Park HS; Matsuoka Y; Santos C; Yang L; Luongo C; Moore IN; Johnson RF; Garza NL; Zhang P; Lusso P; Best SM; Buchholz UJ; Le Nouën C
bioRxiv; 2022 Dec; ():. PubMed ID: 36561185
[TBL] [Abstract][Full Text] [Related]
3. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters.
Liu X; Park HS; Matsuoka Y; Santos C; Yang L; Luongo C; Moore IN; Johnson RF; Garza NL; Zhang P; Lusso P; Best SM; Buchholz UJ; Le Nouën C
PLoS Pathog; 2023 Jun; 19(6):e1011057. PubMed ID: 37352333
[TBL] [Abstract][Full Text] [Related]
4. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
Liu X; Luongo C; Matsuoka Y; Park HS; Santos C; Yang L; Moore IN; Afroz S; Johnson RF; Lafont BAP; Martens C; Best SM; Munster VJ; Hollý J; Yewdell JW; Le Nouën C; Munir S; Buchholz UJ
Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34876520
[TBL] [Abstract][Full Text] [Related]
5. A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
Zhang Y; Lu M; Mahesh KC; Kim E; Shamseldin MM; Ye C; Dravid P; Chamblee M; Park JG; Hall JM; Trivedi S; Chaiwatpongsakorn S; Kenny AD; Murthy SS; Sharma H; Liang X; Yount JS; Kapoor A; Martinez-Sobrido L; Dubey P; Boyaka PN; Peeples ME; Li J
Proc Natl Acad Sci U S A; 2022 Aug; 119(33):e2201616119. PubMed ID: 35895717
[TBL] [Abstract][Full Text] [Related]
6. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys.
Le Nouën C; Nelson CE; Liu X; Park HS; Matsuoka Y; Luongo C; Santos C; Yang L; Herbert R; Castens A; Moore IN; Wilder-Kofie T; Moore R; Walker A; Zhang P; Lusso P; Johnson RF; Garza NL; Via LE; Munir S; Barber DL; Buchholz UJ
Cell; 2022 Dec; 185(25):4811-4825.e17. PubMed ID: 36423629
[TBL] [Abstract][Full Text] [Related]
7. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques.
Nouën CL; Nelson CE; Liu X; Park HS; Matsuoka Y; Luongo C; Santos C; Yang L; Herbert R; Castens A; Moore IN; Wilder-Kofie T; Moore R; Walker A; Zhang P; Lusso P; Johnson RF; Garza NL; Via LE; Munir S; Barber D; Buchholz UJ
bioRxiv; 2022 May; ():. PubMed ID: 35665011
[TBL] [Abstract][Full Text] [Related]
8. Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS-CoV-2 infection.
Zhang Y; Lu M; Thongpan I; Xu J; Kc M; Dravid P; Trivedi S; Sharma H; Liang X; Kapoor A; Peeples ME; Li J
J Med Virol; 2023 Apr; 95(4):e28687. PubMed ID: 36941778
[TBL] [Abstract][Full Text] [Related]
9. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
Cell Rep; 2021 Jul; 36(3):109400. PubMed ID: 34245672
[TBL] [Abstract][Full Text] [Related]
10. A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
bioRxiv; 2020 Dec; ():. PubMed ID: 33299991
[TBL] [Abstract][Full Text] [Related]
11. Intranasal murine pneumonia virus-vectored SARS-CoV-2 vaccine induces mucosal and serum antibodies in macaques.
Kaiser JA; Liu X; Luongo C; Matsuoka Y; Santos C; Yang L; Herbert R; Castens A; Dorward DW; Johnson RF; Park HS; Afroz S; Munir S; Le Nouën C; Buchholz UJ
iScience; 2023 Dec; 26(12):108490. PubMed ID: 38144450
[TBL] [Abstract][Full Text] [Related]
12. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
[TBL] [Abstract][Full Text] [Related]
13. Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens.
DiNapoli JM; Kotelkin A; Yang L; Elankumaran S; Murphy BR; Samal SK; Collins PL; Bukreyev A
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9788-93. PubMed ID: 17535926
[TBL] [Abstract][Full Text] [Related]
14. Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters.
Jia Q; Bielefeldt-Ohmann H; Maison RM; Hartwig A; Masleša-Galić S; Bowen RA; Horwitz MA
Microbiol Spectr; 2023 Mar; 11(2):e0503522. PubMed ID: 36916971
[TBL] [Abstract][Full Text] [Related]
15. MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge.
Meseda CA; Stauft CB; Selvaraj P; Lien CZ; Pedro C; Nuñez IA; Woerner AM; Wang TT; Weir JP
NPJ Vaccines; 2021 Dec; 6(1):145. PubMed ID: 34862398
[TBL] [Abstract][Full Text] [Related]
16. Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2.
Ohtsuka J; Imai M; Fukumura M; Maeda M; Eguchi A; Ono R; Maemura T; Ito M; Yamayoshi S; Kataoka Y; Kawaoka Y; Nosaka T
iScience; 2021 Dec; 24(12):103379. PubMed ID: 34805782
[TBL] [Abstract][Full Text] [Related]
17. Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.
van der Lubbe JEM; Rosendahl Huber SK; Vijayan A; Dekking L; van Huizen E; Vreugdenhil J; Choi Y; Baert MRM; Feddes-de Boer K; Izquierdo Gil A; van Heerden M; Dalebout TJ; Myeni SK; Kikkert M; Snijder EJ; de Waal L; Stittelaar KJ; Tolboom JTBM; Serroyen J; Muchene L; van der Fits L; Rutten L; Langedijk JPM; Barouch DH; Schuitemaker H; Zahn RC; Wegmann F
NPJ Vaccines; 2021 Mar; 6(1):39. PubMed ID: 33741993
[TBL] [Abstract][Full Text] [Related]
18. MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters.
Boudewijns R; Pérez P; Lázaro-Frías A; Van Looveren D; Vercruysse T; Thibaut HJ; Weynand B; Coelmont L; Neyts J; Astorgano D; Montenegro D; Puentes E; Rodríguez E; Dallmeier K; Esteban M; García-Arriaza J
Front Immunol; 2022; 13():845969. PubMed ID: 35371064
[TBL] [Abstract][Full Text] [Related]
19. A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection.
Pérez P; Lázaro-Frías A; Zamora C; Sánchez-Cordón PJ; Astorgano D; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
Front Immunol; 2021; 12():824728. PubMed ID: 35154086
[TBL] [Abstract][Full Text] [Related]
20. A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.
Hassan AO; Feldmann F; Zhao H; Curiel DT; Okumura A; Tang-Huau TL; Case JB; Meade-White K; Callison J; Lovaglio J; Hanley PW; Scott DP; Fremont DH; Feldmann H; Diamond MS
bioRxiv; 2021 Jan; ():. PubMed ID: 33532770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
